BioTrinity Participants


BioTrinity is Europe's Premier BioPartnering and Investment Conference. It brings together investors, pharmaceutical executives and innovative life science R&D companies under one roof. How is this achieved? BioTrinity provides participants with access to each other via one-to-one meetings scheduled through the partnering system; at the panel discussions, where panelists can address the tricky questions of the day and in turn, take questions from the audience; and at the exhibition and social events. The conference offers business activities for all participants that can only be achieved at BioTrinity. With a target attendance of 1,000 participants, including 100 investors, if you need to sell your products and services, your company or even yourself, BioTrinity 2014 offers you that forum as many of BioTrinity participants come to the conference to network, partner and do business with other participants.

BioTrinity 2013 was attended by a number of corporate venturers and senior licensing / business development execs from AbbVie, Amgen, AstraZeneca, Boehringer, Bristol-Myers Squibb, Daiichi Sankyo, Lilly, EUSA, GE, Genus, GSK, Ipsen, J&J, Janssen R&D, Mercury Pharma, MSD, Novartis, Novo Nordisk, Shire, Pfizer, Takeda, Teijin, UCB, Vertex, as well as investors from MedImmune Ventures, SR One, Shire Strategic Investment, AbbVie Biotech Ventures, Mitsui & Co., MPHVM, Norgine Investment Fund, Novartis Venture Fund, Takeda Ventures, Boehringer Ingelheim Ventures, Inventages as well as Syncona, Index, Sofinnova and many many others.   BioTrinity 2014's global corporate and investor participation is even stronger...

Read the testimonials received from delegates from previous years to find out what other delegates say...

Companies Attending BioTrinity 2014:

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M  |  N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z

 

  • AbbVie (USA)
  • AbbVie, Inc (USA)
  • AbD Serotec
  • Ability Pharmaceuticals (Spain)
  • Abingworth LLP
  • Absynth Biologics
  • Actelion Pharmaceuticals (Switzerland)
  • Action on Hearing Loss
  • ActoGeniX NV (Belgium)
  • Addex Therapeutics (Switzerland)
  • Addos
  • Advantage Austria
  • Advent Life Sciences
  • Advent Venture Partners
  • AHA Consulting
  • AIMM Therapeutics BV (Netherlands)
  • Air Liquide UK
  • Air Products plc
  • Akesios Associates
  • Alacrita
  • Albion Ventures LLP
  • Alchemy Pharmatech
  • Alcyomics Ltd
  • Algeta ASA (Norway)
  • ALMAC
  • Almac Discovery
  • Altacor
  • Altran
  • Amakem Therapeutics (Belgium)
  • Amgen (Switzerland)
  • Anacail Ltd
  • Andy Richards
  • ANGLE plc
  • Anima Biotech (Israel)
  • Annexin Pharmaceuticals AB (Sweden)
  • apceth GmbH & Co KG (Germany)
  • Apex Healthcare Consulting
  • Apposite Capital
  • Aptalis Pharmaceutical Technologies (USA)
  • Arachos Pharma
  • Ardington Archives LLP
  • Arecor
  • Array BioPharma Inc (USA)
  • Arthurian Life Sciences
  • Aruwon
  • Asceneuron SA (Switzerland)
  • ASEBIO - Spanish Bioindustry Association (Spain)
  • Astellas Pharma Europe
  • Aston University
  • AstraZeneca (USA)
  • Atelix
  • Atopix Therapeutics
  • Auriga Partners (France)
  • Autifony Therapeutics
  • Avexxin AS (Norway)
  • Axiom Real-Time Metrics Inc (Canada)
  • Banook Group (France)
  • BARC (Belgium)
  • Bay City Capital (US)
  • BBSRC
  • Bench International
  • BerGenBio AS (Norway)
  • Beringea LLP
  • BGI Tech (China)
  • BioAscent Discovery
  • BioCrea (Germany)
  • Biomeva GmbH (Germany)
  • BioPharm Insight
  • Bio-Rad AbD Serotec
  • Biotec Services
  • Biotech Personnel
  • Biotecnol
  • Biovex
  • Bloomberg
  • Bloomberg News
  • Blueberry Therapeutics
  • Bluelane Capital (USA)
  • Boehringer Ingelheim Venture Fund GmbH (Germany)
  • Boehringer Ingelheim RCV GmbH & Co (Austria)
  • Bone Index (Finland)
  • Bone Therapeutics (Belgium)
  • Bordeaux Invest (France)
  • Boult Wade Tennant
  • Brainomix
  • Bristol-Myers Squibb
  • Bristows LLP
  • British Embassy Warsaw (Poland)
  • British Heart Foundation
  • Brown Rudnick LLP
  • Buckinghamshire County Council
  • Cambridge Enterprise
  • Cambridge Healthcare & Biotech
  • Cambridge Innovation Capital plc
  • Catalent
  • Cell Medica
  • Celonic AG (Switzerland)
  • Cempra Inc (USA)
  • Charles River
  • Chiesi (UK)
  • Chronos Therapeutics
  • Citigate
  • Clinical Network Services
  • Cobra Biologics
  • Cogent
  • Coller IP
  • Colworth Park
  • Comberbach Consulting
  • Communications Strategy Group Inc (USA)
  • Confluence Tax LLP
  • Convergence Pharma
  • Cornerstone Therapeutics (USA)
  • Coulter Partners
  • Covington & Burling LLP
  • Creabilis
  • Cresset
  • CTC Clinical Trial Consulting AG (Switzerland)
  • CTC Resourcing Solutions
  • Current Partnering
  • Cyclofluidic
  • Cytox
  • CYP Design
  • Data Magik
  • Datamonitor Healthcare Consulting
  • Debiopharm International S.A. (Switzerland)
  • Dehns
  • DelSiTech (Finland)
  • Delta Partners (Ireland)
  • DFJ Esprit
  • Diamond Pharma Services
  • Dickenson Consulting
  • Domainex
  • Dorphan SA (Switzerland)
  • DSM Fine Chemicals (Austria)
  • Dzaleta Consulting
  • EBD (Switzerland)
  • ECI Partners
  • Edinburgh BioQuarter
  • Edmond de Rothschild Investment Partners (EdRIP) (France)
  • EDRIP (France)
  • Edwards Wildman
  • EEN
  • eg technology
  • Eli Lilly & Company
  • Elsevier
  • EMIG
  • EntreChem SL (Spain)
  • Entrepreneurs Fund
  • EP Vantage
  • Epidarex Capital
  • Eppendorf AG (Germany)
  • Esperante (Netherlands)
  • EUCODIS Bioscience GmbH (Austria)
  • e-Therapeutics plc
  • Eucodis Bioscience (Austria)
  • Eurogentec
  • Euromedica Executive Search
  • EVA Pharma Consulting
  • Evotec UK
  • Exonate
  • EY
  • EYEVENSYS (France)
  • FACE YOUR FACE HandelsGes.m.b.H. (Austria)
  • Ferghana Partners (USA)
  • Ferrer Internacional SA (Spain)
  • Fidelis Research (Bulgaria)
  • Field Fisher Waterhouse LLP
  • Fidelity Biosciences (USA)
  • Finance Wales
  • Fisher Scientific
  • Flanders Investment and Trade
  • Forbion Capital Partners (Netherlands)
  • Forresters
  • Fountain Healthcare Partners (Ireland)
  • F-star Biotechnology
  • FreeMind Group (USA)
  • FTS Bio
  • Gemini Advisors (US)
  • GeneFirst
  • Genzyme Therapeutics
  • george james ltd
  • GFA
  • GfK Market Access
  • GHA
  • GHO Capital
  • Gilde Healthcare Partners (Netherlands)
  • GlaxoSmithKline
  • Glide Pharma
  • GlobalData
  • GLOWING
  • GlycoMar
  • Greater Geneva Berne area (GGBa) (Switzerland)
  • HaemO2
  • Haemostatix
  • Harlan Laboratories, Contract Research Services
  • Healthcare Strategies Group
  • Heidrik & Struggles
  • High Commission of Canada/Ontario Ministry of Economic Development, Trade and Employment (Canada)
  • HitGen Ltd (China)
  • HMR (Hammersmith Medicines Research)
  • HNW Family Fund
  • Horizon Discovery
  • Horton Ruston Poole
  • Illingworth Research
  • Illumina Inc.
  • ILTOO Pharma (France)
  • Imanova
  • IMMUNE Pharmaceuticals (USA)
  • Immunocore
  • Immunservice GmbH (Germany)
  • Immupharma plc
  • Imperial Innovations
  • IMS Health
  • Index Ventures
  • Indigix
  • Industrial Biotechnology Innovation Centre
  • Informa
  • Innovamab (Ireland)
  • Inova Software (France)
  • InSymbiosis (Canada)
  • Intelligent Ultrasound
  • Interceptin (Italy)
  • Interea International
  • International Labmate
  • Inventages Venture Capital
  • Invesco Perpetual
  • Invest in Oxfordshire
  • IP Group plc
  • IP Pragmatics
  • IPF Partners (Luxembourg)
  • iQur
  • IRAD Oncology, Inc (USA)
  • Irving Levin Associates (USA)
  • Isis Innovation
  • J A Kemp
  • James Cowper LLP
  • Johnson & Johnson Development Corporation (USA)
  • Johnson & Johnson Innovation
  • Kalgene Pharmaceuticals Inc (Canada)
  • Karus Therapeutics
  • Ketogen Inc (Canada)
  • Key Organics
  • King's College London
  • Kreos Capital
  • Kuecept
  • KWS BioTest
  • LBA
  • LGC
  • Levicept
  • Life Length (Spain)
  • Life Science Nation (USA)
  • Life Technologies (UK)
  • Liftstream
  • Linde AG (Gemany)
  • Lipopharma Therapeutics (Spain)
  • London BioScience Innovation Centre
  • London Pharma
  • Longcross Advisers LLP
  • Longwall Ventures
  • Lonza
  • LSP Health Economics Fund (Belgium)
  • Ludger
  • Lundbeckfond Ventures (Denmark)
  • Mann Bioinvest
  • M3 (UK)
  • ManxBioMed Cluster (Isle of Man)
  • Mathys & Squire LLP (UK)
  • Mayoly-Spindler (France)
  • MBL International (USA)
  • Medicen (France)
  • MedImmune Ventures (USA)
  • Medivir AB
  • MedNous
  • MEPC Milton Park
  • Mercia Fund Management (UK)
  • Mergermaket Group
  • Merlion Pharmaceuticals Pte (Singapore)
  • Metys Pharmaceuticals (Switzerland)
  • MGB Biopharma  (UK)
  • Midven (UK)
  • MiNA Therapeutics (UK)
  • Mérieux Developpement (France)
  • Mitsui & Co Global Investment (USA)
  • Molecular Profiles
  • Molplex Pharmaceuticals
  • Moorfields Biomedical Research Centre
  • MorEx Development Partners LLP
  • MorphoSys AG (Germany)
  • MP Healthcare Venture Management (USA)
  • MRL Venture Fund (USA)
  • MS Ventures (Switzerland)
  • MSD (UK and US)
  • MVM Life Science Partners
  • Myosotis Therapeutics (Switzerland)
  • Nanobiotix (France)
  • Nanogenic Solutions
  • Nanotether Discovery Sciences (UK)
  • NBGI Ventures (UK)
  • NeoMed (Switzerland)
  • NetScientific plc
  • Neuro-Bio (UK)
  • Neutropion Therapeutics BV (Netherlands)
  • New Enterprise Associates (USA)
  • New Hill Management (UK)
  • NIHR Oxford Biomedical (UK)
  • Nordic Life Science Days (Sweden)
  • Nordic Pharma (Denmark)
  • Norgine
  • Norgine Ventures Investment (UK)
  • Norwich Research Park (UK)
  • Novartis (USA)
  • Novartis Venture Funds (Switzerland)
  • Novo A/S (Denmark)
  • Novo Nordisk
  • Novo A/S (Denmark)
  • Novo Nordisk (Denmark)
  • Novo Seeds (Denmark)
  • Nuevolution (Denmark)
  • Numab AG (Switzerland)
  • O2H Ventures (UK)
  • OBN (UK)
  • OctoPlus (Netherlands)
  • Ontoforce (Belgium)
  • Opal Oncology
  • Opsona Therapeutics (Ireland)
  • Oriel Securities
  • Orthox (UK)
  • Osborne Clarke (UK)
  • OSEM (UK)
  • Oval Insurance Broking  (UK)
  • Oval Medical (UK)
  • Oxford AHSN (UK)
  • Oxford Biomedical Research Centre (UK)
  • Oxford BioTherapeutics (UK)
  • Oxford Brookes University (UK)
  • Oxford Cancer Biomarkers  (UK)
  • Oxford Capital (UK)
  • Oxford Finance (USA)
  • Oxford Science Park (UK)
  • Oxford Spin-out Equity Management (UK)
  • Oxford Technology (UK)
  • OxSonics (UK)
  • Palobiofarma S.L (Spain)
  • Partner International (Canada)
  • Partnership in Practice
  • Patheon (UK)
  • PCI Biotech AS (Norway)
  • Peakdale Molecular
  • Peel Hunt (UK)
  • Penningtons Manches LLP (UK)
  • Peptinnovate Limited (UK)
  • Personalised Healthcare Alliance (UK)
  • Pfizer (UK)
  • PGXIS
  • PharmAbcine Inc (South Korea)
  • Pharmalys
  • pharmaphorum
  • Pharmaterials (UK)
  • Phase4 Partners (UK)
  • Phico Therapeutics (UK)
  • PHOTO DYNAMIC THERAPY LLC (Austria)
  • Physiomics plc (UK)
  • Pinsent Masons (UK)
  • PiR Resourcing (UK)
  • Piramal Healthcare (Discovery Solutions)
  • Piramal Healthcare (Pharma Solutions)
  • PlantForm Corp (Canada)
  • PolyTherics (UK)
  • Potter Clarkson (UK)
  • PRA
  • Preclin Biosystems AG (Switzerland)
  • Premier Research
  • ProFactor Pharma (UK)
  • Progenitor Labs
  • ProImmune
  • Prokarium
  • ProteinLogic
  • PsiOxus Therapeutics
  • Public Health England
  • QIAGEN (USA)
  • QRC Consultants
  • QuantuMDx
  • Quay Pharma
  • Queen Mary University of London
  • Queen's University Belfast
  • QuickSTAT
  • Rare Biotech
  • Reading Scientific Services (UK)
  • RECARDIO (Austria)
  • RECORDATI S.A. (Switzerland)
  • Redoxis (Sweden)
  • Regulatory Resources Group (UK)
  • ReNeuron Group plc (UK)
  • Results Healthcare
  • Retroscreen Virology (UK)
  • Riverbank IT Management (UK)
  • Robert Hollamby (UK)
  • Roche (Switzerland)
  • Rosetta Capital
  • Rostand Productions
  • Royal Society Enterprise Fund (UK)
  • Safeguard Biosystems
  • Samedan (UK)
  • Sanofi-Aventis Research & Development (France)
  • Sanofi-Pasteur MSD (France)
  • Scancell (UK)
  • Scottish Development International (UK)
  • Scottish Enterprise (UK)
  • SCRIP Intelligence (UK)
  • S-cubed (UK)
  • S-cubed Biometrics (UK)
  • SeaLife Pharma (Austria)
  • Selcia (UK)
  • SEP (UK)
  • Sequani
  • Seroba Kernel (Ireland)
  • Seventure Partners (France)
  • Shire Pharmaceutical
  • Silicon Valley Bank
  • Simbec Research
  • SIME Diagnostics
  • Sixth Element Capital
  • Skolkovo Foundation (Russia)
  • Skuldtech (France)
  • SmartSensor Telemed
  • Society of Biology
  • Sofinnova
  • Sofinnova Ventures (Ireland)
  • SPARK Impact
  • Specialty Scanners
  • SR One
  • Stevenage Bioscience Catalyst
  • Summit plc
  • SV Life Sciences
  • Swiss Biotech Association (Switzerland)
  • Swiss Embassy London
  • Sygnature Discovery
  • Symbiosis Pharmaceutical Services
  • Syncona Partners
  • Synergis Technologies
  • Syngene International (India)
  • Synpromics
  • Takeda Pharmaceuticals Europe
  • Takeda Ventures (USA)
  • Talentmark
  • Targovax AS (Norway)
  • TCF Consulting (Belgium)
  • Technology Strategy Board
  • Tecrea
  • Teijin Pharma
  • TheBioTechPanel Inc (Germany)
  • Themis Bioscience GmbH (Austria)
  • Theradex
  • Therapure Biopharma Inc (Canada)
  • Thermo Fisher Scientific (USA)
  • The Pharma Letter
  • The Summit Group
  • Tiber Creek Partners, LLC (USA)
  • TikoMed AB (Sweden)
  • Tillotts Pharma (Switzerland)
  • Tissue Solutions
  • TNO (Netherlands)
  • to-bbb technologies BV (Netherlands)
  • TranScrip Partners LLP
  • Trifermed
  • Triteq
  • Tukan Partners
  • TVM Capital Ventures (Germany)
  • UKTI
  • UKTI London Region
  • UKTI (France)
  • UKTI/British Embassy Moscow (Russia)
  • UKTI/ British Embassy Vilnius (Lithuania)
  • UKTI (UK Trade & Investment) Spain
  • Unilever Ventures (UK)
  • University of Dundee
  • University of Liverpool
  • University of Oxford
  • University of Sussex
  • UroSens
  • Vasgen
  • Vectura plc
  • venBIO LLC (USA)
  • Ventac Partners (Spain)
  • Vertex Pharmaceuticals
  • VHsquared
  • ViraTherapeutics GmbH (Austria)
  • Virttu Biologics
  • Visium Asset Management
  • W Life Sciences (Switzerland)
  • Warwick Ventures
  • Wellcome Trust
  • Wellington Partners (Germany)
  • Welsh Government
  • West of England Academic Health Science Network
  • WG Consulting
  • WilmerHale
  • Withers & Rogers
  • Wombat Capital (USA)
  • World Courier
  • Wragge & Co
  • Wren Capital
  • Xerion Healthcare
  • Yorkville Advisers (USA)
  • Ysios Capital (Spain)
  • Zealand Pharma A/S (Denmark)
  • Zoetis
  • Zysis

 

 

 

 





BioTrinity 2013 highlights
877 delegates from 28 countries
520 companies
168 speakers
86 company presentations
1679 scheduled one-to-one meetings
97 investors from 11 countries
66 exhibitors
32 global pharma/corporate venture